SWSacha Weber

Sacha Weber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sacha Weber has a total of 220 co-authors. Here are the top co-authors by number of shared publications:

  • Antonio Vitobello

    INSERM, CTM UMR1231, équipe GAD, FHU TRANSLAD, Laboratoire de Génomique Médicale Université Bourgogne Europe, CHU Dijon Bourgogne Dijon France

    2 shared publications
  • Laurence Faivre

    Université Bourgogne Europe, CHU Dijon Bourgogne, INSERM, CTM UMR1231, équipe GAD, FHU TRANSLAD, Centre de génétique, Centre de référence Anomalies du Développement et Syndromes Malformatifs, Dijon, France

    2 shared publications
  • Laurence Perrin

    Department of Genetics, UNICAEN, Caen University Hospital Normandy University Caen France

    2 shared publications
  • Sarah Grotto

    AP-HP, Sorbonne Université, Département de Génétique, Paris, France

    2 shared publications
  • Abdias Diaz-Rosado

    Center for Applied Genomics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    1 shared publication
  • Agnès Guichet

    Service de génétique médicale, CHU d'Angers, Angers, France

    1 shared publication

Latest Publications

  • Open Access

    Functional and Structural Characterization of LRRK2 p.V1447L in Parkinson’s Disease

    by Neringa Pratuseviciute, Pawel Lis, Sacha Weber, Nicolas Gruchy, Lionel Arnaud, Dario R Alessi, Esther Sammler

    Background: Gain-of-kinase-function variants in LRRK2 are a leading cause for Parkinson’s disease (PD). Objectives: We tested the functional impact of a novel LRRK2 variant p.V1447L identified in a young onset PD patient in vivo in peripheral blood as well as in a robust cellular assay in addition to other variants in close proximity to V1447. Methods: We measured LRRK2-dependent Rab10 phosphorylation in neutrophils and monocytes of a LRRK2 p.V1447L carrier with PD. We deployed structural modelling and evaluated the impact of additional LRRK2 variants at and around LRRK2 V1447. Results: LRRK2 p.V1447L strongly activates LRRK2 kinase activity. We identified additional variants in the LRRK2 ROC:COR B interface with critical impact on kinase activity and show that different substitutions at the same residue can have opposing effects. Conclusions: We recommend reclassifying LRRK2 p.V1447L from VUS to likely pathogenic. Our study expands the range of putative Loss-of-kinase function variants to LRRK2 missense variants.

  • Open Access

    Blepharophimosis with intellectual disability and Helsmoortel‐Van Der Aa Syndrome share episignature and phenotype

    by Camilla Sarli, Liselot van der Laan, Jack Reilly, Slavica Trajkova, Diana Carli, Alfredo Brusco, Michael A. Levy, Raissa Relator, Jennifer Kerkhof, Haley McConkey, et al.

    Blepharophimosis with intellectual disability (BIS) is a recently recognized disorder distinct from Nicolaides‐Baraister syndrome that presents with distinct facial features of blepharophimosis, developmental delay, and intellectual disability. BIS is caused by pathogenic variants in SMARCA2 , that encodes the catalytic subunit of the superfamily II helicase group of the BRG1 and BRM‐associated factors (BAF) forming the BAF complex, a chromatin remodeling complex involved in transcriptional regulation. Individuals bearing variants within the bipartite nuclear localization (BNL) signal domain of ADNP present with the neurodevelopmental disorder known as Helsmoortel‐Van Der Aa Syndrome (HVDAS). Distinct DNA methylation profiles referred to as episignatures have been reported in HVDAS and BAF complex disorders. Due to molecular interactions between ADNP and BAF complex, and an overlapping craniofacial phenotype with narrowing of the palpebral fissures in a subset of patients with HVDAS and BIS, we hypothesized the possibility of a common phenotype‐specific episignature. A distinct episignature was shared by 15 individuals with BIS‐causing SMARCA2 pathogenic variants and 12 individuals with class II HVDAS caused by truncating pathogenic ADNP variants. This represents first evidence of a sensitive phenotype‐specific episignature biomarker shared across distinct genetic conditions that also exhibit unique gene‐specific episignatures.


  • Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice

    by Sarah E. Sheppard, Laura Bryant, Rochelle N. Wickramasekara, Courtney Vaccaro, Brynn Robertson, Jodi Hallgren, Jason Hulen, Cynthia J. Watson, Victor Faundes, Yannis Duffourd, et al.

    Pathogenic variants in KMT5B , a lysine methyltransferase, are associated with global developmental delay, macrocephaly, autism, and congenital anomalies (OMIM # 617788). Given the relatively recent discovery of this disorder, it has not been fully characterized. Deep phenotyping of the largest ( n = 43) patient cohort to date identified that hypotonia and congenital heart defects are prominent features that were previously not associated with this syndrome. Both missense variants and putative loss-of-function variants resulted in slow growth in patient-derived cell lines. KMT5B homozygous knockout mice were smaller in size than their wild-type littermates but did not have significantly smaller brains, suggesting relative macrocephaly, also noted as a prominent clinical feature. RNA sequencing of patient lymphoblasts and Kmt5b haploinsufficient mouse brains identified differentially expressed pathways associated with nervous system development and function including axon guidance signaling. Overall, we identified additional pathogenic variants and clinical features in KMT5B -related neurodevelopmental disorder and provide insights into the molecular mechanisms of the disorder using multiple model systems.


  • TwoRFC1splicing variants in CANVAS

    by Sacha Weber, Giulia Coarelli, Anna Heinzmann, Marie-Lorraine Monin, Nicolas Richard, Marion Gerard, Alexandra Durr, Vincent Huin

    Sacha Weber, Giulia Coarelli, Anna Heinzmann, Marie-Lorraine Monin, Nicolas Richard, Marion Gerard, Alexandra Durr, Vincent Huin; Two RFC1 splicing variants in


  • Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals

    by Henri Margot, Guilaine Boursier, Claire Duflos, Elodie Sanchez, Jeanne Amiel, Jean-Christophe Andrau, Stéphanie Arpin, Elise Brischoux-Boucher, Odile Boute, Lydie Burglen, et al.